The New Orleans Saints drafted wide receiver Jordyn Tyson 8th overall in the 2026 NFL Draft to surround quarterback Tyler Shough with dynamic weapons during his rookie contract window. 

Now, with Tyson sidelined and already “in the shop” before the regular season begins, the question of whether New Orleans should have invested that pick elsewhere has resurfaced with force.

Tyson is expected to miss roughly two months with a hamstring injury, leaving the Saints thin at wide receiver heading into the 2026 season.

The medical concerns surrounding Tyson were well-documented before the draft. Carnell Tate went 4th overall to the Tennessee Titans, and Tyson went 8th to the Saints. By most evaluations, Tyson’s ceiling, floor, and health profile all carried more risk than Tate’s, which was a potential separator. 

For a team trying to maximize a second-round quarterback’s short four-year rookie contract, investing in a weapon at that spot made ideological sense. The problem is that 8th overall is a massive investment for a player with that kind of injury history, and it looks even more problematic now.

The case for going defense at 8

Before the draft, the alternative was clear: go defense. 

Defensive end Reuben Bain Jr. and safety Caleb Downs were both available at 8 and addressed legitimate needs for New Orleans. Neither carried the medical red flags that Tyson did. Even without the benefit of hindsight, investing a top-10 pick in a player with such high injury risk felt like a gamble.

The Landon Dickerson comparison is worth acknowledging. 

Dickerson dealt with significant injuries in college and has managed to stay relatively healthy in the NFL, turning into a strong selection in retrospect. The difference, though, is that Dickerson was a second-round pick. The Eagles did not invest a top-10 selection in him because they recognized the inherent risk. 

Is this merely a rough start to his career or a harsh reminder about Tyson’s troubling injury history? There’s no crystal ball. That uncertainty is precisely why spending the 8th pick on a player with known medical concerns was always a high-stakes bet.

The receiver depth problem

Here’s the thing about the Saints’ situation: even if they had gone defense at 8, their options to add receiver help later in the draft were limited. 

At pick 42 in the second round, there were not many strong wide receiver options available. Germie Bernard went 47th to the Pittsburgh Steelers, five picks after the Saints’ second-round selection. The rest of the receiver market didn’t materialize until the third round, when players like Malachi Fields, Antonio Williams, and Caleb Douglas came off the board. 

That 2026 NFL Draft was bizarre from top to bottom.

Tight end Kenyon Sadiq was another name that came up as a potential option at 8, but he may not have been worth that kind of investment. He’s a fine pick where the New York Jets took him at No. 16, especially given how valuable versatile tight ends have become in today’s NFL. 

He was not the answer for a team specifically looking to upgrade its wide receiver room for a young quarterback.

Where the Saints stand now

Without Tyson for the foreseeable future, the Saints’ receiver depth behind Chris Olave is thin. Devaughn Vele had a strong end to his 2025 season, and there’s hope he can continue building on that. 

Beyond him, it’s a group of rookies, mid-round additions like Bryce Lance, and late-round fliers like Barion Brown. Reports out of camp have been encouraging for some of those young players, but banking on rookies and developmental pieces to support a quarterback you’re hoping takes a leap is a precarious position.

The rest of the depth chart includes names like Kevin Austin, Ronnie Bell, and Bub Means. Ja’Lynn Polk retired recently, further thinning the group.

New Orleans finds itself in the exact situation that made the Tyson pick feel risky from the start. The Saints needed weapons for Shough, and they swung big on a player whose medical history suggested this outcome was always possible. 

Whether Tyson returns healthy and validates the pick remains to be seen, but right now, the early returns have done nothing to quiet the skeptics.